Amanda has deep experience as an investor in the healthcare industry. She began her career in private equity on Carlyle’s healthcare team and later expanded into venture capital and the public markets. Most recently, she led MedTech investing at Farallon Capital Management and served as a Board Director at Beta Bionics. She holds an A.B. in Applied Mathematics and an M.B.A. from Harvard University